Estimates Revisions Tenax Therapeutics, Inc.
Stocks
TENX
US88032L6056
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.16 USD | -0.22% |
|
+4.29% | +34.50% |
| 12:36pm | Canaccord Genuity Initiates Tenax Therapeutics at Buy With $35 Price Target | MT |
| 11:43am | Canaccord Genuity Initiates Tenax Therapeutics at Buy With $35 Price Target | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- TENX Stock
- Consensus Tenax Therapeutics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
